We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Smartphone-Controlled Microfluidic Device Enables Rapid Influenza Detection

By LabMedica International staff writers
Posted on 15 Jul 2024
Print article
Image: Schematic illustration of the SEDphone system workflow (Photo courtesy of ZHU Cancan)
Image: Schematic illustration of the SEDphone system workflow (Photo courtesy of ZHU Cancan)

The influenza virus represents a significant public health concern, annually causing epidemics with high morbidity and mortality rates. The virus is known for its high mutation rate and the existence of multiple subtypes, which require varied clinical approaches. Consequently, there is a critical need for an accurate, rapid, and portable method to differentiate between influenza virus subtypes to manage virus transmission and inform clinical treatment decisions. Researchers have now developed a spatial encoding of a centrifugal microfluidic disc-integrated smartphone-controlled (SEDphone) platform for detecting influenza virus subtypes.

In a study, researchers from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences (Anhui, China) developed a novel approach that combines Loop-mediated Isothermal Amplification (LAMP) with CRISPR/Cas12a technologies for rapid and accurate detection of various influenza viruses. This method amplifies target sequences using LAMP and detects them through CRISPR/Cas12a-mediated trans-cleavage activity, thus cleaving reporter probes and emitting fluorescent signals. This technique is highly sensitive and reduces the occurrence of false positives. To aid the detection of different influenza strains, the researchers devised a flexible model capable of targeting multiple flu types. Following optimization, this method can identify five influenza types (H1N1, H3N2, H5N1, H7N9, and Influenza B) within 45 minutes, even at low viral concentrations (10 copies/μL).

Furthermore, to facilitate simultaneous LAMP amplification and CRISPR detection, the team engineered a centrifugal microfluidic chip with spatial encoding features. They also developed a portable testing device, dubbed SEDphone, which operates via smartphone control. This device can simultaneously amplify and detect multiple influenza virus types. Incorporating a dual temperature zone design, it addresses the temperature variance required for both technologies. Clinical sample testing confirmed that this innovative method and the SEDphone device are effective in rapidly identifying various influenza subtypes. The research results were published in Sensors and Actuators: B. Chemical.

"Our research offers a new way to quickly and accurately detect various pathogens in real-time. This method can be used in fever clinics or at home, helping to reduce the risk of unnecessary cross-infection and easing the burden on healthcare systems," said Dr. ZHU Cancan, a member of the research team.

Related Links:
Hefei Institutes of Physical Science

Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Plasmodium Parasites Test
Plasmodium Genotyping Real Time PCR Kit
New
Chagas Rapid Test
OnSite Chagas Ab Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The new platelet-centric scoring system predicts platelet hyperreactivity and related risk of cardiovascular events (Photo courtesy of Shutterstock)

Blood Platelet Score Detects Previously Unmeasured Risk of Heart Attack and Stroke

Platelets, which are cell fragments circulating in the blood, play a critical role in clot formation to stop bleeding. However, in some individuals, platelets can become "hyperreactive," leading to excessive... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: The Accelerate WAVE system delivers rapid AST directly from positive blood culture bottles (Photo courtesy of Accelerate Diagnostics)

Rapid Diagnostic System to Deliver Same-Shift Antibiotic Susceptibility Test Results

The World Health Organization estimates that sepsis impacts around 49 million people worldwide each year, resulting in roughly 11 million deaths, with about 1.32 million of these deaths directly linked... Read more

Pathology

view channel
A schematic of the 3D MM imaging experimental setup used in the studies of blood films (Photo courtesy of Ushenko, A.G., et al.; doi.org/10.1038/s41598-024-63816-z)

Novel Light-Based Technique With 90% Accuracy Rate to Revolutionize Cancer Diagnosis

A quicker, cheaper, and less painful cancer detection technique developed using light has the potential to revolutionize cancer diagnosis, early detection, and monitoring. Researchers at Aston Institute... Read more

Industry

view channel
Image: The QIAstat-Dx IVD panel for neurodegenerative applications will be integrated with the QIAstat-Dx multiplex testing platform (Photo courtesy of QIAGEN)

Qiagen and Eli Lilly to Develop First QIAstat-Dx IVD Panel for Neurodegenerative Applications

QIAGEN N.V. (Venlo, the Netherlands) has entered into a collaboration with Eli Lilly and Company (Indianapolis, IN, USA) to support the development of a QIAstat-Dx in-vitro diagnostic (IVD) to detect APOE genotypes.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.